INHIBITION OF EXUDATE PRODUCTION BY ANTI-INFLAMMATORY DRUGS.
D000893:Anti-Inflammatory Agents; D002744:Chlorpheniramine; D002746:Chlorpromazine; D003850:Deoxyribonuclease I; D005122:Exudates and Transudates; D006821:Hyaluronoglucosaminidase; D006854:Hydrocortisone; D007249:Inflammation; D010600:Pharmacology; D011239:Prednisolone; D011398:Promethazine; D051381:Rats; D012106:Research; D012980:Sodium Salicylate; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D014291:Trimeprazine; D014357:Trypsin
D000893:Anti-Inflammatory Agents; D002744:Chlorpheniramine; D014291:Trimeprazine; D011239:Prednisolone; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D006821:Hyaluronoglucosaminidase; D013300:Streptokinase; D014357:Trypsin; D011398:Promethazine; D002746:Chlorpromazine; D006854:Hydrocortisone; D012980:Sodium Salicylate
ANTI-INFLAMMATORY AGENTS; CHLORPHENIRAMINE; CHLORPROMAZINE; EXPERIMENTAL LAB STUDY; EXUDATES AND TRANSUDATES; HYALURONIDASE; HYDROCORTISONE; INFLAMMATION; PHARMACOLOGY; PREDNISOLONE; PROMETHAZINE; RATS; SODIUM SALICYLATE; STREPTODORNASE AND STREPTOKINASE; TRIMEPRAZINE; TRYPSIN